Iranian researchers assigned 63 type 2 diabetes patients to placebo or broccoli sprout powder (10 g or 5 g) daily for four weeks.
Research published in the European Journal of Clinical Nutrition suggests that broccoli sprout powder may reduce oxidative stress in people with type 2 diabetes.
According to recent science, oxidative stress appears to play a major role in the development of type 2 diabetes. Broccoli sprouts may protect the body from that damage, thanks to sulforaphane, a compound found in cruciferous vegetables.
Researchers at the Shahid Beheshti University of Medical Sciences (Tehran, Iran) assigned 63 type 2 diabetes patients to placebo or broccoli sprout powder (10 g or 5 g) daily for four weeks. Cyvex Nutrition Inc. (Irvine, CA) provided sulforaphane-standardized broccoli sprout powder (BroccoPhane) for the study.
After four weeks of supplementation, broccoli sprout supplementation was associated with a 9% decrease in serum malondialdehyde (a product of lipid peroxidation) and a 5% decrease in low-density lipoprotein (LDL) cholesterol for the highest intake group. Total antioxidant capacity was increased by 16% and 10% in the high and low intake groups respectively.
The results of this study support previous work on humans and animals, according to the researchers.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.